Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078912 | SCV000110772 | benign | not specified | 2013-05-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000129391 | SCV000184157 | benign | Hereditary cancer-predisposing syndrome | 2014-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000078912 | SCV000304387 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000406309 | SCV000410734 | benign | Peutz-Jeghers syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Invitae | RCV000406309 | SCV000554137 | benign | Peutz-Jeghers syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000129391 | SCV000686626 | benign | Hereditary cancer-predisposing syndrome | 2015-04-08 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001536943 | SCV001156742 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001536943 | SCV001753760 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000406309 | SCV002057396 | benign | Peutz-Jeghers syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000129391 | SCV002531678 | benign | Hereditary cancer-predisposing syndrome | 2020-10-20 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000078912 | SCV002551947 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149766 | SCV003838122 | benign | Breast and/or ovarian cancer | 2021-07-07 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000406309 | SCV004015560 | benign | Peutz-Jeghers syndrome | 2023-07-07 | criteria provided, single submitter | clinical testing | |
True Health Diagnostics | RCV000129391 | SCV000788217 | likely benign | Hereditary cancer-predisposing syndrome | 2018-01-03 | no assertion criteria provided | clinical testing | |
Faculté Pluridciplinaire Nador, |
RCV001250944 | SCV001250927 | likely benign | Squamous cell lung carcinoma | 2020-05-05 | no assertion criteria provided | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001357260 | SCV001552679 | benign | Malignant tumor of breast | no assertion criteria provided | clinical testing | The STK11 p.Ile88= variant was not identified in the literature nor was it identified in the MutDB, LOVD 3.0, Zhejiang Colon Cancer Database, or Insight Hereditary Tumors Database. The variant was identified in the following databases: dbSNP (ID: rs56354945) as “With other allele”, ClinVar (as likely benign by Illumina and benign by Emory Genetics, Ambry Genetics, PreventionGenetics, and Invitae), Clinvitae (4x), and Cosmic. The variant was identified in control databases in 1969 of 264616 chromosomes (67 homozygous) at a frequency of 0.007441 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). Observations by population include African in 1688 (66 homozygous) of 22648 chromosomes (freq: 0.07453), Other in 26 of 6226 chromosomes (freq: 0.004176), Latino in 175 (1 homozygous) of 33114 chromosomes (freq: 0.005285), European (Non-Finnish) in 76 of 120564 chromosomes (freq: 0.00063), and South Asian in 4 of 29712 chromosomes (freq: 0.000135); the variant was not observed in the Ashkenazi Jewish, East Asian, European (Finnish) populations. The p.Ile88= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. | |
Genome Diagnostics Laboratory, |
RCV000078912 | SCV001807299 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000078912 | SCV001917838 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000078912 | SCV001953503 | benign | not specified | no assertion criteria provided | clinical testing |